Modra Pharmaceuticals   Report issue

For profit Phase 2
Founded: Amsterdam Netherlands (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2017
NCT03136640
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Modra Pharmaceuticals